SHAN; Song

Patent Applications and Registrations

Patent applications and USPTO patent grants for SHAN; Song.The latest application filed is for "chiauranib for treatment of small cell lung cancer".

Company Profile

1.6.14

SHAN; Song - Guangdong CN
SHAN; Song - Shenzhen Guangdong

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Kdm5a Gene And Atrx Gene App 20220184056 - LU; Xianping ; et al.	2022-06-16
Chiauranib For Treatment Of Small Cell Lung Cancer App 20220184055 - LU; Xianping ; et al.	2022-06-16
Quinoline Derivative Having Indoleamine-2,3-dioxygenase Inhibitory Activity App 20210379052 - YU; Jindi ; et al.	2021-12-09
Combination Of Histone Deacetylase Inhibitor And Protein Kinase Inhibitor And Pharmaceutical Use Thereof App 20210315881 - LU; Xianping ; et al.	2021-10-14
Formamide Compound, Preparation Method Therefor And Application Thereof App 20210139454 - YANG; Qianjiao ; et al.	2021-05-13
Substituted Phenylpropionic Acid Enantiomer And Manufacturing Method, Composition, And Application Of Same App 20200031771 - YU; Jindi ; et al.	2020-01-30
Preparation method for aromatic heterocyclic compound used as selective JAK3 and/or JAK1 kinase inhibitor and application of aromatic heterocyclic compound Grant 10,011,571 - Lu , et al. July 3, 2	2018-07-03
Preparation Method For Aromatic Heterocyclic Compound Used As Selective Jak3 And/or Jak1 Kinase Inhibitor And Application Of Aromatic Heterocyclic Compound App 20170253566 - LU; Xianping ; et al.	2017-09-07
Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors Grant 8,211,901 - Lu , et al. July 3, 2	2012-07-03
Naphthamide Derivatives As Multi-Target Protein Kinase Inhibitors and Histone Deacetylase Inhibitors App 20100298358 - LU; Xian-Ping ; et al.	2010-11-25
Benzamide derivatives as histone deacetylase inhibitors with potent differentiation and anti-proliferation activity Grant 7,550,490 - Lu , et al. June 23, 2	2009-06-23
Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity App 20080051321 - Lu; Xian-Ping ; et al.	2008-02-28
Histone Deacetylase Inhibitors or Novel Benzamine Derivatives with Potent Differentiation and Anti-Proliferation Activity App 20080039509 - Lu; Xian-Ping ; et al.	2008-02-14
Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity Grant 7,268,157 - Lu , et al. September 11, 2	2007-09-11
Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity Grant 7,244,751 - Lu , et al. July 17, 2	2007-07-17
Noncyclic 1,3-Dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity App 20070142427 - Lu; Xian-Ping ; et al.	2007-06-21
Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity Grant 7,192,970 - Lu , et al. March 20, 2	2007-03-20
Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity App 20040224991 - Lu, Xian-Ping ; et al.	2004-11-11
Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity App 20040142921 - Lu, Xian-Ping ; et al.	2004-07-22
Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity App 20040138211 - Lu, Xian-Ping ; et al.	2004-07-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.